VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)— 510(k) K120466

Substantially Equivalent

Nanosphere, Inc.

FDA 510(k) clearance K120466 for VERIGENE CYP2C19 NUCLEIC ACID TES (2C19), Substantially Equivalent on 2012-11-06. Applicant: Nanosphere, Inc..

Clearance details

Applicant: Nanosphere, Inc.
Product code: Code NTI
Advisory panel: Clinical Toxicology
Date received: 2012-02-15
Decision date: 2012-11-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Northbrook, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.